Testosterone replacement therapy (TRT) may promote prostate cancer tumor growth.
Low testosterone may increase cardiovascular (CV) risk in middle-aged men with type 2 diabetes.
Testosterone therapy for men who produce little to no hormones does not increase heart attack risk.
When it comes to erectile dysfunction (ED) in middle-aged men, testosterone may not be a key factor.
Joint committee also calls for drug makers to run heart-risk tests on popular 'Low T' products.
Expert panel to decide whether prescribing information on testosterone drugs should be changed.
Chemicals found in many household products may reduce androgen levels in both sexes.
Obesity can lead to a deterioration of erectile function in young men.
Finding runs counter to some prior reports; much larger trials are needed, experts say.
In a study, 74% of men treated with Vogelxo achieved normal testosterone levels within 90 days.
Researchers report findings from a study of 942 hypogonadal men treated at 3 German centers.
Exposure to prenatal testosterone accounts for many of the differences between men and women, particularly in the brain.
The product is self-administered via a nasal applicator.
Study also shows a 6-fold higher rate of hypogonadism compared with the general population.
For men with T2DM and low testosterone, tx also doesn't improve visceral adiposity.